Walter Stadler, MD
@wmstadler.bsky.social
Chief Clinical Officer, City of Hope Chicago
On this #WorldCancerResearchDay, apply for the @conquercancer.bsky.social Career Development Award (CDA) to secure mentored clinical oncology funding. Open to US & international initial faculty. Apply by Oct 8: https://bit.ly/4iK0tWc #ResearchConquersCancer
Applications are open for the @conquercancer.bsky.social International Innovation Grant (IIG)! 🧠 This grant supports oncology researchers residing in LMICs who are driving innovative, locally-focused cancer control projects. Submit your Letter of Intent by August 27, 2026: https://bit.ly/4hrQ150
Way too frequently. Only slightly worse than genuflecting at p<0.05 as the breakpoint for “positive” vs “negative”
Has anyone been noticing folks are starting to say "numerically superior" to describe results that are not statistically significant?
PSM is incredibly difficult to define & there are other benefits to not developing advanced prostate cancer (e.g. avoiding androgen ablation). As such mortality statistics for screening any disease with decades long natural history are a, but not the only metric we should follow.
PSA screening reduces cancer-specific mortality (PCSM). Questions remain about effect on all-cause (OS). PSA could reduce PCSM not OS only with deaths from other causes, eg complications of surgery. Please reply with list of screening-induced causes of death.
We've updated Patient-Clinician Communication guidelines. New recommendations cover: 💬 Core communication skills 🔎 Prognosis & treatment selection 🫶 End-of-life care 🥼 Clinician training Improving the dialogue for better cancer care. Read the update: https://bit.ly/3NnMnMR
In 1991, US cancer death rates hit an all-time high. Advances in early detection & treatment helped bring mortality rates down, averting 4.5 million deaths. Tell your lawmakers to support cancer research funding: brnw.ch/21wXB3j #SaveResearchStopCancer #ASCOAdvocacy
Investing in research today prevents suffering tomorrow & ensures our national scientific standing. We cannot turn away from millions counting on American ingenuity to live healthier lives. #ASCOAdvocacy #SaveResearchStopCancer Take action with us: brnw.ch/21wVvP3
The acting head of the CDC is a tech bro with no medical training who embraced Covid conspiracy theories. Talk about malpractice.
A Dangerous Liaison
Trump and RFK Jr. play politics with public health and safety
steady.substack.com
50 years ago, surviving cancer was a rarity. Federally funded research changed that for millions of Americans. But progress is now at risk. Unstable funding threatens to halt future breakthroughs #SaveResearchStopCancer #ASCOAdvocacy Take action with us: brnw.ch/21wVh17
Calling all scientists and science supporters! You have a crucial role to play in countering the authoritarian threat we currently face in this country. Learn more about how you can stand up for the facts and truth that are essential for a free and democratic society. blog.ucs.org/gretchen-gol...
PBS News is not going anywhere. We will continue our work without fear or favor, as we have for nearly five decades on the air. We are profoundly grateful to Viewers Like You for your loyalty and unwavering support.
Join us at Best of ASCO Minneapolis, July 11-12, for the cutting-edge research selected by experts in your field, and while you’re there take advantage of some of the best the city has to offer! Don't forget to register: brnw.ch/21wTX02
"Patients with grade group (GG) 1 on biopsy can have higher grade disease on surgery. So GG1 = cancer". But also true of benign: "Patients with benign on biopsy can have higher grade disease on surgery"
🇺🇸Take @ascocancer.bsky.social action today: 1️⃣ The proposed federal budget requires significant reductions in spending 2️⃣ >70M rely on Medicaid for healthcare, including millions of Americans with cancer 3️⃣ Write Congress & demand Medicaid be protected It's easy! asco.quorum.us/campaign/115...
Medicaid
Urge Congress to Protect Cancer Patients on Medicaid
asco.quorum.us
George Weiner: Cancer centers are special, as are site visits in CCSG review https://cancerletter.com/guest-editorial/20250509_2/
George Weiner: Cancer centers are special, as are site visits in CCSG review - The Cancer Letter
The cancer center program of the NCI is a success that is admired not only within the NIH but worldwide. This is due, in large part, to the cancer center review process that has evolved and strengthened over the years. To access this subscriber-only content please log in or subscribe.If your institution has a site […]
cancerletter.com
ASCO is calling on lawmakers to uphold the U.S.’s role as a global leader in scientific and medical innovation and preserve vital federal cancer prevention and research funding. #ASCOAdvocacy Read our statement: shorturl.at/kZwjr
This needs to be amplified. The unfortunate increase in cancers in young individuals, especially for colorectal cancer, has created a public narrative that cancer rates are increasing
The data are clear. Cancer mortality rates have been decreasing. And this is, undoubtedly, because of cancer research that results in new treatments. Medical research saves lives. pressroom.cancer.org/2025CancerFa...
April is Testicular Cancer Awareness Month – a time to recognise the prevalence of this Below the Belt cancer and the incredible people working to improve outcomes. Their dedication is driving better treatments, improving patient care, and bringing hope to those affected.💙👏
It’s a travesty, but how do we respond? Is this a scenario where we argue there’s an individual need for each of these cancers or can we speak with one voice that cancer research is critical? In my view there’s a “divide & conquer” approach here.
#kidneycancer #LungCancer #pancreaticcancer & #Glioblastoma = all defunded within CDMRP this year by Pete Hegseth, Sen. McConnell & Rep. Calvert. Cancer is supposed to be nonpartisan. 591,000+ Americans are expected to be diagnosed w/ 1 of these this year. What will we tell them? #oncsky #medsky
Katie provides the moral imperative far more eloquently than I can. For those who require an economic argument, the US research enterprise is the most robust in the world creating $100B in wealth. It is one of our most successful exports.
has crushed me in a way I can not describe. If you have ever celebrated me and my fight against the odds, I need you to also support science in this moment. This isn't about politics, it crosses party lines. Cancer research needs us right now.
.@ascocancer.bsky.social engages in judicial and legislative advocacy to protect NIH funding: www.asco.org/news-initiat...
ASCO Engages in Judicial and Legislative Advocacy to Protect NIH Funding - ASCO
asco.org
The response of the science community to the last month is not about one statement or action. It's about all of us with our different frames. For Science's part, we are doing what we have always done and have no plans to change. My thoughts on what we can do. www.science.org/doi/10.1126/...
Come together, right now
The chaos, conflicting information, firings, and hurtful rhetoric of the Trump administration’s approach to science over the past month are causing anxiety, grief, and concern for the scientific commu...
science.org
We are committed to advancing policies that improve patient access to high-quality cancer care. We continue to collaborate with all stakeholders to address existing barriers and ultimately improve cancer care for those in need.
‘Lose-lose-lose’ scenario: ASCO seeks reduced out-of-pocket costs for cancer care
Out-of-pocket costs like deductibles and copays deter people with cancer from complying with treatment.This creates a “lose-lose-lose” scenario for patients, payers and employers, Clifford...
healio.com
With this logic pts who are heavy smokers should be labeled as “group 1 lung cancer” because of their high risk for clinically significant lung cancer.
Another argument against removing “cancer” label for Pattern 3 easily prostate cancer refuted by replacing “pattern 3” with “benign”: men with pattern 3 / biopsy and PSA > 20 are at increased risk of mortality therefore call pattern 3 / benign “cancer” euoncology.europeanurology.com/article/S258...
We applaud new draft guidance from the @fda.gov & OHRP on incl tissue biopsies in clinical trials. In The Cancer Letter editorial, we stated guidance closely aligns w our ongoing efforts to improve ethics of research biopsies, esp biopsies that are mandatory. More: brnw.ch/21wQetz
ASCO Applauds New Draft Guidance on Including Tissue Biopsies in Clinical Trials
ASCO welcomes new draft guidance on including tissue biopsies in clinical trials.
brnw.ch